Aspire Private Capital’s Trillium Therapeutics Inc. TRIL Stock Holding History

Aspire Private Capital’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20	Closed	–	–	696
2021 Q3	$0	Buy	+20	New	+$234	﹤0.01%	665
2021 Q1	–	Sell	-20	Closed	–	–	625
2020 Q4	$0	Hold	20	–	–	﹤0.01%	557
2020 Q3	$0	Buy	+20	New	+$199	﹤0.01%	526

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Aspire Private Capital's TRIL Position: Q4 2021 in Review

Aspire Private Capital sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 20 shares.

Aspire Private Capital first reported a position in TRIL in Q3 2020 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Aspire Private Capital reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Aspire Private Capital sold 20 Trillium Therapeutics Inc. shares in Q4 2021.
Aspire Private Capital first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 3 quarters.
Aspire Private Capital's Trillium Therapeutics Inc. position peaked at $0 in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Aspire Private Capital's 13F filing for Q4 2021, filed 14 Feb 2022.